Martinelli, G <br/><br/>
Quantification of BCR-ABL transcripts in CML patients in cytogenetic remission after interferon-alpha-based therapy.  [electronic resource] 

 -  Bone marrow transplantation  Apr 2000 
 - 729-36 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0268-3369 
<br/><br/><label>Standard No.: </label>10.1038/sj.bmt.1702207  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antineoplastic Agents--therapeutic use<br/>Bone Marrow Cells--pathology<br/>Bone Marrow Transplantation<br/>Combined Modality Therapy<br/>Cytarabine--therapeutic use<br/>Disease-Free Survival<br/>Female<br/>Follow-Up Studies<br/>Fusion Proteins, bcr-abl--genetics<br/>Genes, abl<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--therapeutic use<br/>Karyotyping<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy<br/>Male<br/>Middle Aged<br/>Recombinant Proteins<br/>Remission Induction<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Time Factors<br/>Transcription, Genetic<br/>Transplantation, Autologous